The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA—At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.
University of California San Diego Distinguished Professor of Physics and Neurobiology David Kleinfeld is a leading expert in sensory processing and mouth-face-head movements. Through a highly competitive process, a new $21 million grant from the National Institutes of Health (NIH) will allow him and a team of researchers to continue studying the coordination of multiple sensory inputs and head movements using laboratory mice and rats.
A research team led by Iowa State's Zhaoyu Wang will study electric vehicle charging stations with a goal of developing strategies and technologies to keep the chargers operating, even when storms hit and the power goes out.
A grant from the National Institutes of Health will support ongoing research at Wayne State University investigating the consequences environmental factors may have on fertility in males.
Tufts University researchers have received a $20.7 million grant to lead the largest NIH-funded prospective study of patients with chronic Lyme disease to date, following patients from their earliest diagnosis to better identify why some people go on to develop debilitating symptoms later on.
A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.
Blueprint MedTech is a National Institutes of Health (NIH) technology incubator program that is part of the NIH Blueprint for Neuroscience Research and for the past two years has provided funding and expertise to fast-track the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems.
The LJI team uncovered important similarities between H5N1 and these common viruses, which allowed them to predict that many people already have "cross-reactive" T cells that are ready to target H5N1—should it ever mutate to cause widespread disease in humans.
A study of hundreds of people using medical marijuana reported “rapid and significant improvements” in health-related quality of life over the first three months, according to new research led by Philadelphia College of Osteopathic Medicine (PCOM).
Glen Hood, Ph.D., assistant professor of biological sciences in Wayne State University’s College of Liberal Arts and Sciences, was recently awarded a National Science Foundation grant for his study of parasitic wasps.
A new study from researchers at Wake Forest University School of Medicine shows that inpatient food insecurity, experienced by caregivers during their child’s hospitalization, is associated with not only longer hospital admissions but also significantly increased odds of readmission.
WashU Medicine scientists lead two large, multicenter programs to develop vaccines and antibody-based therapies for understudied viruses with pandemic potential. The programs are supported by two grants from the National Institute for Allergy and Infectious Diseases (NIAID) totaling more than $30 million a year for three years.
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.
Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to participate in a broad national effort to develop "plug-and-play" vaccines and antibody-based therapies against a wide range of emerging viruses. The grant is part of NIAID’s new Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network, which was announced earlier today.
Mount Sinai study could lead to new treatments for fibromuscular dysplasia
A UC Davis Health study found 22% of adults and 10% of children who participated in an air-quality study in California’s San Joaquin Valley were breathing detectable levels of pesticides.
A new USDA-supported project based at Iowa State University will create an encyclopedia of livestock species' genetic regulatory regions, a DNA netherworld that could be useful in breeding for improved animal efficiency and health.
Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate antibodies and gene editing to improve the outcome of this breakthrough treatment for patients.
In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.
A protein called torsinA plays a key role in the early development of neurons, determining where nuclear pores are placed in the membrane that encloses the nucleus of nerve cells, a study led by UT Southwestern Medical Center researchers shows.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right